Detalhe da pesquisa
1.
SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis.
Mol Cancer Ther
; 23(2): 223-234, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871911
2.
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.
Sci Adv
; 10(13): eadm9859, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536921
3.
Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion.
J Vis Exp
; (197)2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486129
4.
SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis.
bioRxiv
; 2023 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37214958
5.
Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy.
NPJ Breast Cancer
; 9(1): 52, 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311792
6.
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.
bioRxiv
; 2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37425844
7.
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growth.
bioRxiv
; 2023 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37502974
8.
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance.
Cell Rep
; 42(11): 113295, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37889752